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ARTICLE OPEN
Symptom-based screening tool for asthma syndrome among
young children in Uganda
Rebecca Nantanda1,3✉, Volkert Siersma2, Grace Ndeezi3, James K. Tumwine3 and Marianne S. Østergaard 2
Under-diagnosis of asthma in ‘under-fives’ may be alleviated by improved inquiry into disease history. We assessed a questionnaire-
based screening tool for asthma among 614 ‘under-fives’ with severe respiratory illness in Uganda. The questionnaire responses
were compared to post hoc consensus diagnoses by three pediatricians who were guided by study definitions that were based on
medical history, physical examination findings, laboratory and radiological tests, and response to bronchodilators. Children with
asthma or bronchiolitis were categorized as “asthma syndrome”. Using this approach, 253 (41.2%) had asthma syndrome. History of
and present breathing difficulties and present cough and wheezing was the best performing combination of four questionnaire
items [sensitivity 80.8% (95% CI 77.6–84.0); specificity 84.7% (95% CI 81.8–87.6)]. The screening tool for asthma syndrome in ‘under-
fives’ may provide a simple, cheap and quick method of identifying children with possible asthma. The validity and reliability of this
tool in primary care settings should be tested.
npj Primary Care Respiratory Medicine           (2020) 30:18 ; https://doi.org/10.1038/s41533-020-0175-1
INTRODUCTION
Childhood asthma is common but is largely under-diagnosed,
while bacterial pneumonia is over-diagnosed1–4. Among children
under five years of age (‘under-fives’ or U-5s) the signs and
symptoms of acute asthma and pneumonia overlap, and this
creates difficulty in distinguishing asthma from pneumonia even
among the experienced2,3,5. Consequently, many children with
asthma are misdiagnosed as pneumonia. Over-diagnosis of
pneumonia is associated with over-use of antibiotics and
worsening antibiotic resistance and withholding asthma medi-
cines for children who need them6–9. Failure to diagnose and treat
asthma is associated with repeated hospital visits, avoidable high
healthcare costs and low quality of life of affected children and
their families10,11 Un-treated asthma also affects growth and
development of the affected children12,13. Furthermore, several
studies have reported that the pathologic features of asthma;
inflammation and basement membrane thickening, start before 3
years of age14. Hence, early identification of asthma may prevent
permanent airway changes15.
Epidemiologically, children with wheeze have been retrospec-
tively categorized into three; (1) transient, (2) persistent and (3)
late onset based on cohort data. However, this classification has
no clinical significance because it does not provide guidance on
how and when to intervene16,17. Recently, two wheezing
phenotypes among young children have been described accord-
ing to temporal symptom patterns, and these are; (1) episodic viral
wheeze which refers to discrete periods of wheezing associated
with symptoms of a viral cold only, and multiple-trigger wheeze in
which wheezing is present with or without viral episodes16.
Multiple-trigger wheeze responds to short-acting bronchodilators
(SABA), possibly due to underlying asthma. However, identifying
these children requires recognition of the wheezing episodes by
parents/caretakers so that they can narrate them to clinicians
during consultation. However, this is challenging because of poor
recognition of wheeze by caretakers18–21. Therefore, using this
approach alone may not comprehensive identify children with
possible/at risk of asthma, hence the need for a wider scope of
symptoms to assess.
Acute bronchiolitis, especially due to rhinovirus and to a lesser
extent RSV is a risk factor for development of asthma later in
childhood22–25. Different studies have indicated that up to 30% of
children hospitalized with acute bronchiolitis develop asthma, and
that such children may respond to SABA, possibly due to
underlying hyper-responsive airways26–28. A pragmatic approach
that highlights this possibility is therefore useful in increasing the
index of suspicion of asthma in children, such that they can be
diagnoseds and managed early.
The diagnosis of asthma, and indeed other airway diseases such
as pneumonia, in young children is very dependent on inquiry
into the clinical history of the disease process. There is a lack of
useable diagnostic tests for airflow limitation and airway
inflammation in this age group. Other diagnostic tools such as
X-ray may not be readily available in primary care health facilities
and may require extensive travel with a sick child. This is
aggravated in rural areas and in low-income countries where
even availability of health care specialists may be limited. For
many, a clear and detailed history on the disease presentation is
the most reasonable first-line approach to determining diagnosis
and treatment.
Using the Integrated Management of Childhood Illnesses (IMCI)
guidelines29, the World Health Organization (WHO) attempts to
use the symptom of wheeze to diagnose asthma in young
children but this does not perform well and many children with
asthma remain undiagnosed1. Furthermore, the IMCI guidelines
use wheezing as the only symptom to diagnose asthma, yet,
studies have reported that the symptom of wheeze is poorly
understood by both caretakers and health workers19,30. Hence,
there is a need for a more comprehensive overview of the use of
information on the clinical history and presentation to identify
children with probable asthma. The objective of the present paper
1Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda. 2The Research Unit for General Practice and Section of General Practice,
Department of Public Health, University of Copenhagen, Copenhagen, Denmark. 3Department of Paediatrics and Child Health, Makerere University College of Health Sciences,
Kampala, Uganda. ✉email: rnantanda@gmail.com
www.nature.com/npjpcrm
Published in partnership with Primary Care Respiratory Society UK
1
2
3
4
5
6
7
8
9
0
()
:,;
is to assess the performance of a screening tool for asthma among
children <5 years of age, based on inquiry into symptoms
and signs.
RESULTS
General overview
Six hundred and fourteen children (614) were included in the
study. The majority (80.2%) of the children were aged 24 months
and below. The median age was 10 months (Interquartile range:
6–18). Three hundred and fourty seven (347) (56.5%) were boys.
Of the 614 participants, 468 (76.0%) were from urban settings. The
number of children who were diagnosed with asthma or
bronchiolitis were categorized as “asthma syndrome” and
contributed 253 (41.2%) participants. Of the 253 children who
were diagnosed with asthma syndrome, 125 (49.4%) had acute
bronchiolitis while 78 (30.8%) had asthma alone and 50 (19.8%)
had a combination of asthma and bacterial pneumonia. The
details of the diagnoses are provided in Table 1.
Response to bronchodilator therapy was one of the criteria used
for diagnosis of asthma, and of the 253 children with asthma
syndrome, 128 (50.6%) of them responded to bronchodilators. The
remaining 125 children did not respond to bronchodilators and
were categorized as having bronchiolitis.
Individual APQ questionnaire items to identify children with
asthma syndrome
Table 2 presents the ten items of the 88 in the Ugandan APQ
questionnaire that have the best diagnostic properties with
respect to the AUC. Only the item that asks about present
wheezing has properties that are reasonably acceptable. Many of
the other top items also ask about wheezing in some form, but
here the sensitivity is far below acceptable. We observed that even
with the top item more than a sixth of the children (17.4%) were
misclassified.
Sets of APQ items to screen for asthma syndrome in young
children
In an attempt to improve on the performance of the single items
for screening for asthma, combinations of items were investigated
to assess if the diagnostic properties can be improved. Table 3
presents the combination of four items that performed best. This
combination had a sensitivity of 78.3% (95% CI 75.1–81.6), a
specificity of 86.6% (95% CI 83.9–89.3), AUC of 82.5% (95% CI
80.4–84.6) and a MCE of 17.0% (95% CI 15.2–19.3). This is only a
marginal improvement on the single wheezing item presented in
Table 2.
The analyses were repeated after stratifying the participants by
age; 492 (80.1%) children <2 years of which 192 (39.0%) had
asthma syndrome, and 122 (19.1%) aged 2–5 years of which 61
(50.0%) had asthma syndrome. For both age groups, wheezing
was the best performing single item in screening for children with
possible asthma with sensitivity 77.1% (95% CI 70.8–82.6) and
specificity 83.7% (95% CI 79.2–87.6) for children <2 years, and
sensitivity 90.2% (95% CI 81.1–96.0) and specificity 88.5%
(82.9–94.1) for children aged 2 up to 5 years. Also for both age
groups, as for the complete data, wheezing was part of the best
performing combination of four items and the performance of the
combinations was not better than the performance of the single
wheeze item: sensitivity 75.4% (95% CI 71.6–79.2), specificity
85.7% (95% CI 82.6–88.7) for children <2 years and sensitivity
93.3% (95% CI 88.9–97.8), specificity 91.9% (95% CI 87.1–96.8) for
children 2–5 years. The sensitivity and specificity of both the
individual wheeze item and the best performing combination was
higher for children aged 2 up to 5 years.
DISCUSSION
In this study, we aimed at investigating the use of inquiry into
symptoms and signs for the screening for asthma syndrome in U-
5s when presenting with cough and/or difficult breathing. The
questionnaire comprised items regarding acute and chronic
respiratory symptoms.
Generally, the findings indicate that it is possible to correctly
classify children with probable asthma using only the clinical
history in up to 80% of cases. In low-income settings where there
are limited skilled personnel and diagnostics, and under-diagnosis
of asthma3,29,31, these symptoms can be very useful in guiding the
process of screening and subsequent diagnosis of asthma among
children <5 years. Although wheeze is one of the major symptoms
of asthma in children, it is poorly understood and expressed by
caretakers in many settings18-20. This could explain why the
symptom of wheeze alone did not perform any better than the
combination of symptoms.
The results show that using a set of items such as cough,
wheezing and breathing difficulties, and importantly, previous
attacks of breathing difficulties, we can correctly identify more
than three-quarters (81%) of children with asthma syndrome.
Some studies have attempted to develop tools for screening and/
or diagnosis of pediatric asthma. However, these studies were
done in older children and in high income countries32,33. There is
scarcity of data on tools for detection of asthma in young children,
yet, they are the most affected by asthma symptoms4,34,35. A few
studies have identified symptoms that can be used for the
diagnosis of asthma in children <5 years5,36. In India, Sachdev and
others studied children aged 2–59 months and identified two
symptoms that were predictive of asthma; (1) previous episodes of
Table 1. Demographic characteristics of the study participants (N= 614).
Diagnosis Total (n) Percentage (%) Age group
(months)
Sex Residence
<12 ≥12 M F Urban Rural
Bronchiolitis 125 20.4 109 16 85 40 99 26
Asthma 78 12.7 20 58 42 36 64 14
Combined asthma and bacterial pneumonia 50 8.1 17 33 29 21 37 13
Bacterial pneumonia 167 27.2 77 90 95 72 129 38
Viral pneumonia 163 26.5 92 71 82 81 122 41
Othersa 31 5.0 18 13 14 17 17 14
Total 614 100 333 281 347 267 468 146
aPulmonary tuberculosis, pneumocystis jirovecii pneumonia.
R Nantanda et al.
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cough and difficulty in breathing and (2) having had no fever at
the time of presentation with acute respiratory symptoms5.
Another study by Gowraiah et al.36 reported that a history of
previous episodes of acute respiratory symptoms and wheeze
were predictive of wheezy disease among young children, and
that such children were more likely to have asthma rather than
pneumonia. The findings in this study are similar to those of
previous studies and emphasize the need to look at a combination
of acute and chronic/recurrent asthma symptoms in asthma case
detection.
The symptoms that were identified are also closely related to
the definition of asthma in young children as outlined in various
international guidelines such as GINA37. This points to the fact that
they can be applicable in clinical practice, and should be
considered for validation and subsequent adaptation into primary
care guidelines such as IMCI29. Furthermore, these tools are based
on symptoms, and this is in conformity with the syndromic/
symptom-based approach in screening and diagnosis of child-
hood illnesses that has been found to be feasible and useful in
settings such as Uganda, which have limited human resources for
health and diagnostics38. Such tools will go a long way in helping
healthcare workers in low-income settings to identify and refer
children with probable asthma syndrome for further evaluation.
Most individual symptoms had very low sensitivity or specificity,
indicating the limitations associated with one symptom to screen
for asthma in children. However, the symptom of wheeze
performed well in predicting asthma syndrome. The performance
did not improve when combinations of symptoms were con-
sidered. Further analysis after stratifying the children into those <2
years and 2 years up to 5 years also showed that the symptom of
wheeze was important in screening children for asthma syndrome
in both age groups. This indicates that for children <5 years, the
symptom of wheeze is key in identifying children who may have
asthma. This is similar to the approach used in the IMCI guidelines
where it is used to identify children with asthma. However,
understanding and expressing the symptom of wheeze by
caretakers remains a challenge18–21 indicating the need for further
research into simple items to guide the diagnosis of asthma
syndrome in U-5s.
The methodological approach to this study provided for a
comprehensive process of developing the questionnaire items,
piloting them for understanding and relevance and using a
diagnostic criteria for asthma and pneumonia based on interna-
tional guidelines and incorporating laboratory and radiological
test results. The APQ was developed using an iterative process
including pre-testing in Uganda. This comprehensive process
ensured that the scope of questionnaire items was wide and
relevant to the study setting. However, some of the asthma
questionnaire items, particularly those referring to recurrence of
symptoms were prone to recall bias. The diagnostic process was
based on clinical assessment supported by laboratory and
radiological tests, and response to treatment, which is in line
with international guidelines for diagnosis of asthma in children37.
Therefore, the diagnoses made were deemed accurate.
The study had a large sample size, was rigorous and used a
pragmatic approach to defining asthma syndrome which is
relevant to many low-income settings and therefore the results
would be useful in similar settings. However, they can only be
generalized to tertiary care settings and are not directly applicable
to rural and other primary care settings, because the study site
was a tertiary care hospital where patients are very heterogeneous
with many children (75%) from urban settings. In addition, the
acute symptoms such as wheezing may be performing well
because of the hospital setting where doctors may be explicitly
using the term wheezing, which may not be the case in primary
care settings. Therefore, the wheezing item may be performing
well artificially. Lastly, the IMCI guidelines were developed for
primary care settings with limited diagnostic capabilities,T
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therefore, the tools identified in this study need to be validated in
primary care settings before adaptation.
The results from this study show that the sensitivity and
specificity of the screening tool for children with asthma
syndrome were acceptable: the items of previous attacks of
breathing difficulties and presently cough, wheezing and
breathing difficulties can correctly identify more than three-
quarters (81%) of under-fives with asthma syndrome. It is
envisaged that this tool can provide a simple, cheap and quick
method of identifying children with possible asthma syndrome.
A study to test the validity and reliability of this tool is
recommended to test its usefulness in primary care settings
where there are limited skilled personnel and diagnostics.
Screening for asthma using this approach would be very helpful
in clinical practice and contribute towards mitigating the
problem of under-diagnosis of asthma.
METHODS
Study design, setting and recruitment
This was a cross-sectional survey among U-5s presenting with respiratory
symptoms at the pediatric emergency unit of Mulago Hospital in Kampala.
Mulago hospital is the Ugandan national referral hospital and the teaching
hospital of Makerere University College of Health Sciences. At the time of
the study, the daily attendance at the pediatric emergency unit was 50–70
children, and 25% of these presented with cough and/or difficult
breathing. The hospital was selected as the study site because of its
ability to handle laboratory and radiological investigations for diagnosis of
asthma and pneumonia, facilities that are not readily available in other
public hospitals in the country.
The process of recruiting participants into the study has been described
in detail elsewhere39. Briefly, between August 2011 and July 2012, children
aged 2–59 months who presented with cough and/or difficult breathing,
and fast breathing were eligible for inclusion. Children with heart
conditions or cardiac failure secondary to severe anemia, based on the
caretaker’s history, physical examination findings and medical records,
were excluded. Following informed written consent from the caretaker, the
Asthma-Pneumonia Questionnaire (APQ) was administered followed by a
physical examination. Children who had wheezing received nebulized
salbutamol. They had their response recorded, and systemic steroids were
given to those who had moderate or severe symptoms. Children who were
suspected to have pneumonia were given antibiotics according to the
hospital protocol40.
The APQ questionnaire
The Asthma-Pneumonia Questionnaire (APQ) was developed in a
qualitative study in Denmark through an iterative process with clinical
experts13. At the outset, six dimensions of interest for U-5s with cough or
breathing difficulty were identified: complaints at presentation, history of
symptoms, history of asthma medicine use, family history of asthma and
environmental factors. The final version of this Danish questionnaire
contained 60 items focusing on the medical history, to be filled out by the
child’s primary caretaker. The development of the Danish APQ ques-
tionnaire was done in Denmark spearheaded by MSO. It was then adapted
for use in Uganda by RN. The process of adaptation of the questionnaire
involved translation of the questionnaire into Luganda the language
commonly used in central Uganda, where Mulago hospital is located. It
was then back-translated into English. Both the Luganda and English
versions were pre-tested on a sample of 35 mothers to check for
applicability and understanding of the questionnaire items and time taken
to administer the questionnaire. This process also helped to identify items
that needed to be added onto the questionnaire to suit the local setting.
The necessary changes were made and the final Ugandan APQ
questionnaire consisting of 88 items was developed (Additional File 1).
Diagnosis of asthma
The diagnoses were based on a systematic approach of the history, clinical
examination, laboratory results and chest radiographs, as well as response
to short-acting bronchodilators. The details of the laboratory methods
have been described previously39. Briefly, total white cell and differential
counts, and C-reactive protein (CRP) were done to screen for possible viral
or bacterial pneumonia. Blood culture was done for diagnosis of bacterial
pneumonia and a nasopharyngeal swab for isolation of RSV using
immunofluorescence technique. A chest X-ray was done to try and
distinguish pneumonia from asthma. An expert panel of three senior
pediatricians with experience in pediatric pulmonology and infectious
diseases reviewed the case record form for each participant. The experts
had no access to the participants. Hence, the diagnoses were made post
hoc. Each expert studied the case record form of the participant and,
guided by the study definitions, made a diagnosis of asthma or otherwise
(pneumonia, bronchiolitis), which was then discussed by all the three
experts. A final diagnosis was made if there was concordance between at
least two of the three experts. Where there was discordance between all
the three experts, the case record forms were subjected to further
Table 3. The best performing set of four items for detection of asthma syndrome in U-5s with acute respiratory symptoms.
Disease start with
difficulty in
breathing?
Did painkillers
help much?
Your child’s disease
today: wheezing/
whistling?
Did your child had significant
cough in the last few days (just
before coming to the hospital)?
n Indicated
diagnosis
Without
asthma in
data (%)
With asthma
in data (%)
No No No No 1 Asthma 0.0 100.0
Yes No No No 2 No asthma 50.0 50.0
No Yes No No 0
Yes Yes No No 3 No asthma 100.0 0.0
No No Yes No 0
Yes No Yes No 2 Asthma 0.0 100.0
No Yes Yes No 0
Yes Yes Yes No 0
No No No Yes 127 No asthma 86.6 13.4
Yes No No Yes 40 No asthma 85.0 15.0
No Yes No Yes 147 No asthma 87.8 12.2
Yes Yes No Yes 34 No asthma 79.4 20.6
No No Yes Yes 78 Asthma 17.9 82.1
Yes No Yes Yes 76 Asthma 17.1 82.9
No Yes Yes Yes 57 Asthma 31.6 68.4
Yes Yes Yes Yes 47 Asthma 25.5 74.5
R Nantanda et al.
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discussion until a diagnosis was agreed upon. All discussions and
conclusions were guided by international case definitions of asthma in
children37. The participants were assigned one of the following diagnoses
based on the criteria; asthma, bronchiolitis, bacterial pneumonia,
combined asthma and bacterial pneumonia, viral pneumonia and other
(pneumocystis jirovecii pneumonia, pulmonary tuberculosis). The details of
the diagnostic criteria (Additional File 2) have been published1. RN took
the minutes during these proceedings but did not participate in the
discussions.
Prior to conducting the study, we performed a literature review and
consulted experienced clinicians to generate a study definition of
asthma37,41–43. This definition was based on a combination of the clinical
history, examination findings, results of tests and response to treatment.
Briefly, the definition of asthma was based on the Global Initiative for
Asthma (GINA) guidelines37 that was modified as follows: in the history we
excluded “recurrent chest tightness” as a symptom because it is not easily
expressed by U-5s44,45. We also excluded peak expiratory flow measure-
ments and spirometry because U-5s are not able to perform these tests
effectively46. Furthermore, we included chest X-rays to help us distinguish
asthma from pneumonia. Bronchiolitis was defined as a first episode of
wheezing with cough and/or difficult breathing in association with
respiratory distress47.
The term “Asthma syndrome” was used to refer to children with asthma
and bronchiolitis because, among young children, it is difficult to
differentiate asthma from bronchiolitis due to the overlap in clinical
presentation and uncertainty in recordings of the medical history2. Using
the label ‘asthma’ essentially implies a similar approach to treatment for
children with asthma and bronchiolitis. In addition, asthma is a chronic
illness, often starting in infancy48,49 and characterized by continuous
review, hence, the use of the term asthma syndrome affords an
opportunity for re-evaluation of the children with asthma symptoms and
eventual identification of those with asthma.
Statistical considerations
For each of the items in the questionnaire, the sensitivity, specificity, area
under the curve (AUC), area under the receiver operating characteristic
(ROC) curve (the mean of the sensitivity and specificity), Positive Predictive
Value (PPV), Negative Predictive Value (NPV) and misclassification error
(MCE) defined as the proportion of children wrongly classified with regard
to asthma in the present population, were calculated with 95% CI. We
sought to improve the performance of the single items by devising a
diagnosis based on a combination of items. A diagnosis based on a
combination of items is readily defined from the data at hand as for each
possible combination of answers to return the diagnosis corresponding to
the most prevalent gold standard diagnosis. In order to investigate the
performance of a diagnosis approach based on a combination of items, we
investigated all combinations of four items. The combinations with the
best performance give an upper limit to the performance of such approach
based on combinations of items.
To assess an item with both sensitivity and specificity of at least 80%, in
a population with an estimated asthma prevalence of 46%, a sample of 534
children was required3,50. Data were double-entered in Epidata version 3.0;
analyses were done in SAS version 9.4 and R version.
Ethical considerations
Ethical approval was obtained from the Higher Degrees, Ethics and
Research Committee (HDREC) at Makerere College of Health Sciences and
the Uganda National Council of Science and Technology (UNCST). Informed
written consent was obtained from the caretakers of the children.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
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author on reasonable request.
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